findmyKOL

Bonnie Bermas, MD

Basic profile

The University of Texas Southwestern Medical Center

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Bonnie Bermas is a Rheumatology/Immunology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 181 publications with 4,594 citations (h-index 35).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
181publications

Distinct works indexed by OpenAlex, matched via ORCID.

4,594citations

Total citations across indexed works.

35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Utsw Division Of Rheumatic Diseases 2001 Inwood Road
8th Floor Suite C
Dallas, TX 752847208

Telephone

142-645-2800

Registry record last updated 29 May 2019.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    36.1%
    Folate Analog Metabolic Inhibitor15.4%
    Methotrexate100%
    Part D42 patients
    TNF inhibitor9.8%
    Humira Pen31%Humira(Cf) Pen30%Enbrel Sureclick29%Humira10%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    26.4%
    Corticosteroid20.8%
    Prednisone100%
    Part D52 patients
    Antidiarrheal microorganisms2.8%
    Folic Acid100%
    Part D11 patients

    + 1 more class in this area

  • Nervous system

    16%
    Nonsteroidal Anti-inflammatory Drug5.4%
    Meloxicam100%
    Part D16 patients
    Cholinergic Receptor Agonist3.3%
    Cevimeline Hcl100%
    Part D<11 patients

    + 4 more classes in this area

Where care is delivered (Part B)5.4% facility · 94.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”